Quick Takeaways
- Glenn Sblendorio has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $212,536.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Glenn Sblendorio and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Director | $212,536 | 19 Feb 2026 | ||
| FOLD | AMICUS THERAPEUTICS, INC. | Director | $0 | 27 Apr 2026 | ||
| FDMT | 4D Molecular Therapeutics, Inc. | Director | 05 Jan 2026 | |||
| ICPT | INTERCEPT PHARMACEUTICALS, INC. | Director | 08 Nov 2023 | |||
| ISEE | IVERIC bio, Inc. | Chief Executive Officer, Director | 11 Jul 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|